Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 287048, 10 pages
http://dx.doi.org/10.1155/2015/287048
Review Article

Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology

1Department of Human Genetics, National Health Institute Dr. Ricardo Jorge, Avenida Padre Cruz, 1649-016 Lisboa, Portugal
2Biosystems and Integrative Sciences Institute (BioISI), Faculty of Sciences, University of Lisbon, 1749-016 Lisboa, Portugal

Received 20 October 2014; Accepted 16 December 2014

Academic Editor: Elena Orlova

Copyright © 2015 Vânia Gonçalves and Peter Jordan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Chen and J. L. Manley, “Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches,” Nature Reviews Molecular Cell Biology, vol. 10, no. 11, pp. 741–754, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Castello, B. Fischer, K. Eichelbaum et al., “Insights into RNA biology from an atlas of mammalian mRNA-binding proteins,” Cell, vol. 149, no. 6, pp. 1393–1406, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Ray, H. Kazan, K. B. Cook et al., “A compendium of RNA-binding motifs for decoding gene regulation,” Nature, vol. 499, no. 7457, pp. 172–177, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. K. J. Hertel, “Combinatorial control of exon recognition,” The Journal of Biological Chemistry, vol. 283, no. 3, pp. 1211–1215, 2008. View at Publisher · View at Google Scholar
  5. C. W. J. Smith and J. Valcárcel, “Alternative pre-mRNA splicing: the logic of combinatorial control,” Trends in Biochemical Sciences, vol. 25, no. 8, pp. 381–388, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. L. Manley and A. R. Krainer, “A rational nomenclature for serine/arginine-rich protein splicing factors (SR proteins),” Genes and Development, vol. 24, no. 11, pp. 1073–1074, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. J. Smith, C. Zhang, J. Wang, S. L. Chew, M. Q. Zhang, and A. R. Krainer, “An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers,” Human Molecular Genetics, vol. 15, no. 16, pp. 2490–2508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. J. R. Sanford, X. Wang, M. Mort et al., “Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts,” Genome Research, vol. 19, no. 3, pp. 381–394, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. F. Lareau, M. Inada, R. E. Green, J. C. Wengrod, and S. E. Brenner, “Unproductive splicing of SR genes associated with highly conserved and ultraconserved DNA elements,” Nature, vol. 446, no. 7138, pp. 926–929, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Valacca, S. Bonomi, E. Buratti et al., “Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene,” The Journal of Cell Biology, vol. 191, no. 1, pp. 87–99, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Sun, Z. Zhang, R. Sinha, R. Karni, and A. R. Krainer, “SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control,” Nature Structural and Molecular Biology, vol. 17, no. 3, pp. 306–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. J. R. Sanford, P. Coutinho, J. A. Hackett, X. Wang, W. Ranahan, and J. F. Caceres, “Identification of nuclear and cytoplasmic mRNA targets for the shuttling protein SF2/ASF,” PLoS ONE, vol. 3, no. 10, Article ID e3369, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Verduci, M. Simili, M. Rizzo et al., “MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis,” Journal of Biological Chemistry, vol. 285, no. 50, pp. 39551–39563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Meseguer, G. Mudduluru, J. M. Escamilla, H. Allgayer, and D. Barettino, “MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF),” The Journal of Biological Chemistry, vol. 286, no. 6, pp. 4150–4164, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. C. Hagopian, C.-T. Ma, B. R. Meade et al., “Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1,” Journal of Molecular Biology, vol. 382, no. 4, pp. 894–909, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-C. Lai, R.-I. Lin, and W.-Y. Tarn, “Transportin-SR2 mediates nuclear import of phosphorylated SR proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10154–10159, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. J. F. Cáceres, T. Misteli, G. R. Screaton, D. L. Spector, and A. R. Krainer, “Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity,” Journal of Cell Biology, vol. 138, no. 2, pp. 225–238, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Kataoka, J. L. Bachorik, and G. Dreyfuss, “Transportin-SR, a nuclear import receptor for SR proteins,” Journal of Cell Biology, vol. 145, no. 6, pp. 1145–1152, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Colwill, T. Pawson, B. Andrews et al., “The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution,” EMBO Journal, vol. 15, no. 2, pp. 265–275, 1996. View at Google Scholar · View at Scopus
  20. J. C. K. Ngo, S. Chakrabarti, J.-H. Ding et al., “Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2,” Molecular Cell, vol. 20, no. 1, pp. 77–89, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Ghosh and J. A. Adams, “Phosphorylation mechanism and structure of serine-arginine protein kinases,” The FEBS Journal, vol. 278, no. 4, pp. 587–597, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Misteli, J. F. Cáceres, and D. L. Spector, “The dynamics of a pre-mRNA splicing factor in living cells,” Nature, vol. 387, no. 6632, pp. 523–527, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-F. Gui, W. S. Lane, and X.-D. Fu, “A serine kinase regulates intracellular localization of splicing factors in the cell cycle,” Nature, vol. 369, no. 6482, pp. 678–682, 1994. View at Publisher · View at Google Scholar · View at Scopus
  24. J.-H. Ding, “Regulated cellular partitioning of SR protein-specific kinases in mammalian cells,” Molecular Biology of the Cell, vol. 17, pp. 876–885, 2005. View at Publisher · View at Google Scholar
  25. T. Giannakouros, E. Nikolakaki, I. Mylonis, and E. Georgatsou, “Serine-arginine protein kinases: a small protein kinase family with a large cellular presence,” FEBS Journal, vol. 278, no. 4, pp. 570–586, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Zhou, J. Qiu, W. Liu et al., “The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus,” Molecular Cell, vol. 47, no. 3, pp. 422–433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. B. E. Aubol, R. M. Plocinik, J. C. Hagopian et al., “Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases,” Journal of Molecular Biology, vol. 425, no. 16, pp. 2894–2909, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. X.-Y. Zhong, J.-H. Ding, J. A. Adams, G. Ghosh, and X.-D. Fu, “Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones,” Genes and Development, vol. 23, no. 4, pp. 482–495, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Shi, W. Qian, X. Yin et al., “Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease,” The Journal of Biological Chemistry, vol. 286, no. 16, pp. 14639–14648, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. K. Aksaas, S. Eikvar, G. Akusjärvi, B. S. Skålhegg, and A. K. Kvissel, “Protein Kinase a-dependent phosphorylation of serine 119 in the proto-oncogenic serine/arginine-rich splicing factor 1 modulates its activity as a splicing enhancer protein,” Genes and Cancer, vol. 2, no. 8, pp. 841–851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Rossi, E. Labourier, T. Forné et al., “Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I,” Nature, vol. 381, no. 6577, pp. 80–82, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Labourier, F. Rossi, I.-E. Gallouzi, E. Allemand, G. Divita, and J. Tazi, “Interaction between the N-terminal domain of human DNA topoisomerase I and the arginine-serine domain of its substrate determines phosphorylation of SF2/ASF splicing factor,” Nucleic Acids Research, vol. 26, no. 12, pp. 2955–2962, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Soret, M. Gabut, C. Dupon et al., “Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I,” Cancer Research, vol. 63, no. 23, pp. 8203–8211, 2003. View at Google Scholar · View at Scopus
  34. M. Malanga, A. Czubaty, A. Girstun, K. Staron, and F. R. Althaus, “Poly(ADP-ribose) binds to the splicing factor ASF/SF2 and regulates its phosphorylation by DNA topoisomerase I,” Journal of Biological Chemistry, vol. 283, no. 29, pp. 19991–19998, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. X. Li and J. L. Manley, “Inactivation of the SR protein splicing factor ASF/SF2 results in genomic instability,” Cell, vol. 122, no. 3, pp. 365–378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. A. El Hage, S. L. French, A. L. Beyer, and D. Tollervey, “Loss of Topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis,” Genes and Development, vol. 24, no. 14, pp. 1546–1558, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Blaustein, F. Pelisch, T. Tanos et al., “Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT,” Nature Structural & Molecular Biology, vol. 12, no. 12, pp. 1037–1044, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Jiang, N. A. Patel, J. E. Watson et al., “Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCβJII messenger ribonucleic acid,” Endocrinology, vol. 150, no. 5, pp. 2087–2097, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Wang, Z. Zhou, A. Hu et al., “Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt,” Molecular Cell, vol. 54, no. 3, pp. 378–391, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Naro, F. Barbagallo, P. Chieffi, C. F. Bourgeois, M. P. Paronetto, and C. Sette, “The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival,” Nucleic Acids Research, vol. 42, no. 5, pp. 3218–3227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Cazalla, J. Zhu, L. Manche, E. Huber, A. R. Krainer, and J. F. Cáceres, “Nuclear export and retention signals in the RS domain of SR proteins,” Molecular and Cellular Biology, vol. 22, no. 19, pp. 6871–6882, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. D. G. Nowak, E. M. Amin, E. S. Rennel et al., “Regulation of Vascular Endothelial Growth Factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis,” Journal of Biological Chemistry, vol. 285, no. 8, pp. 5532–5540, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Goncalves, A. Henriques, J. Pereira et al., “Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells,” RNA, vol. 20, no. 4, pp. 474–482, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Misteli and D. L. Spector, “Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors,” Molecular Biology of the Cell, vol. 7, no. 10, pp. 1559–1572, 1996. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Novoyatleva, B. Heinrich, Y. Tang et al., “Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing,” Human Molecular Genetics, vol. 17, no. 1, pp. 52–70, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. C.-T. Ma, G. Ghosh, X.-D. Fu, and J. A. Adams, “Mechanism of dephosphorylation of the SR protein ASF/SF2 by protein phosphatase 1,” Journal of Molecular Biology, vol. 403, no. 3, pp. 386–404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. G. Biamonti and J. F. Caceres, “Cellular stress and RNA splicing,” Trends in Biochemical Sciences, vol. 34, no. 3, pp. 146–153, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. F. J. Blanco and C. Bernabéu, “The splicing factor SRSF1 as a marker for endothelial senescence,” Frontiers in Physiology, vol. 3, article 54, 2012. View at Publisher · View at Google Scholar
  49. V. Leva, S. Giuliano, A. Bardoni et al., “Phosphorylation of SRSF1 is modulated by replicational stress,” Nucleic Acids Research, vol. 40, no. 3, pp. 1106–1117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Sinha, E. Allemand, Z. Zhang, R. Karni, M. P. Myers, and A. R. Krainer, “Arginine methylation controls the subcellular localization and functions of the oncoprotein splicing factor SF2/ASF,” Molecular and Cellular Biology, vol. 30, no. 11, pp. 2762–2774, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. V. Tripathi, D. Y. Song, X. Zong et al., “SRSF1 regulates the assembly of pre-mRNA processing factors in nuclear speckles,” Molecular Biology of the Cell, vol. 23, no. 18, pp. 3694–3706, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Kurogi, Y. Matsuo, Y. Mihara et al., “Identification of a chemical inhibitor for nuclear speckle formation: Implications for the function of nuclear speckles in regulation of alternative pre-mRNA splicing,” Biochemical and Biophysical Research Communications, vol. 446, no. 1, pp. 119–124, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. V. Gonçalves, P. Matos, and P. Jordan, “The β-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression,” RNA, vol. 14, no. 12, pp. 2538–2549, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. Ú. Muñoz, J. E. Puche, R. Hannivoort, U. E. Lang, M. Cohen-Naftaly, and S. L. Friedman, “Hepatocyte growth factor enhances alternative splicing of the Krüppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1,” Molecular Cancer Research, vol. 10, no. 9, pp. 1216–1227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  55. V. R. Moulton, A. R. Gillooly, and G. C. Tsokos, “Ubiquitination regulates expression of the serine/argininerich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells,” Journal of Biological Chemistry, vol. 289, no. 7, pp. 4126–4134, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. A. K. Yadav, V. Vashishta, N. Joshi, and P. Taneja, “AR-A 014418 used against GSK3beta downregulates expression of hnRNPA1 and SF2/ASF splicing factors,” Journal of Oncology, vol. 2014, Article ID 695325, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  57. O. Breig and F. Baklouti, “Proteasome-mediated proteolysis of SRSF5 splicing factor intriguingly co-occurs with SRSF5 mRNA upregulation during late erythroid differentiation,” PLoS ONE, vol. 8, no. 3, Article ID e59137, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. H. Sato, N. Hosoda, and L. E. Maquat, “Efficiency of the pioneer round of translation affects the cellular site of nonsense-mediated mRNA decay,” Molecular Cell, vol. 29, no. 2, pp. 255–262, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. M.-C. Lai and W.-Y. Tarn, “Hypophosphorylated ASF/SF2 binds TAP and is present in messenger ribonucleoproteins,” The Journal of Biological Chemistry, vol. 279, no. 30, pp. 31745–31749, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. J. R. Sanford, N. K. Gray, K. Beckmann, and J. F. Cáceres, “A novel role for shuttling SR proteins in mRNA translation,” Genes & Development, vol. 18, no. 7, pp. 755–768, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. M. M. Maslon, S. R. Heras, N. Bellora, E. Eyras, and J. F. Cáceres, “The translational landscape of the splicing factor SRSF1 and its role in mitosis,” eLife, vol. 2014, no. 3, Article ID e02028, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Blaustein, L. Quadrana, G. Risso, M. De La Mata, F. Pelisch, and A. Srebrow, “SF2/ASF regulates proteomic diversity by affecting the balance between translation initiation mechanisms,” Journal of Cellular Biochemistry, vol. 107, no. 4, pp. 826–833, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Michlewski, J. R. Sanford, and J. F. Cáceres, “The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E-BP1,” Molecular Cell, vol. 30, no. 2, pp. 179–189, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. Z. Zhang and A. R. Krainer, “Involvement of SR proteins in mRNA surveillance,” Molecular Cell, vol. 16, no. 4, pp. 597–607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Wu, S. Sun, K. Tu et al., “A splicing-independent function of SF2/ASF in microRNA processing,” Molecular Cell, vol. 38, no. 1, pp. 67–77, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Pelisch, J. Gerez, J. Druker et al., “The serine/arginine-rich protein SF2/ASF regulates protein sumoylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 37, pp. 16119–16124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. R. J. Loomis, Y. Naoe, J. B. Parker et al., “Chromatin binding of SRp20 and ASF/SF2 and dissociation from mitotic chromosomes is modulated by histone H3 serine 10 phosphorylation,” Molecular Cell, vol. 33, no. 4, pp. 450–461, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. M. M. Pradeepa, H. G. Sutherland, J. Ule, G. R. Grimes, and W. A. Bickmore, “Psip1/Ledgf p52 binds methylated histone H3K36 and splicing factors and contributes to the regulation of alternative splicing,” PLoS Genetics, vol. 8, no. 5, Article ID e1002717, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. V. Visconte, H. Makishima, J. P. MacIejewski, and R. V. Tiu, “Emerging roles of the spliceosomal machinery in myelodysplastic syndromes and other hematological disorders,” Leukemia, vol. 26, no. 12, pp. 2447–2454, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. C. Ghigna, M. Moroni, C. Porta, S. Riva, and G. Biamonti, “Altered expression of heterogeneous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas,” Cancer Research, vol. 58, no. 24, pp. 5818–5824, 1998. View at Google Scholar · View at Scopus
  71. E. Stickeler, F. Kittrell, D. Medina, and S. M. Berget, “Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis,” Oncogene, vol. 18, no. 24, pp. 3574–3582, 1999. View at Publisher · View at Google Scholar · View at Scopus
  72. J. P. Venables, “Aberrant and alternative splicing in cancer,” Cancer Research, vol. 64, no. 21, pp. 7647–7654, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. R. Karni, E. De Stanchina, S. W. Lowe, R. Sinha, D. Mu, and A. R. Krainer, “The gene encoding the splicing factor SF2/ASF is a proto-oncogene,” Nature Structural and Molecular Biology, vol. 14, no. 3, pp. 185–193, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. S. Gout, E. Brambilla, A. Boudria et al., “Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma,” PLoS ONE, vol. 7, no. 10, Article ID e46539, 2012. View at Publisher · View at Google Scholar · View at Scopus
  75. L. Zou, H. Zhang, C. Du et al., “Correlation of SRSF1 and PRMT1 expression with clinical status of pediatric acute lymphoblastic leukemia,” Journal of Hematology and Oncology, vol. 5, article 42, 2012. View at Publisher · View at Google Scholar · View at Scopus
  76. W. P. Tansey, “Mammalian MYC proteins and cancer,” New Journal of Science, vol. 2014, Article ID 757534, 27 pages, 2014. View at Publisher · View at Google Scholar
  77. S. Das, O. Anczuków, M. Akerman, and A. R. Krainer, “Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC,” Cell Reports, vol. 1, no. 2, pp. 110–117, 2012. View at Publisher · View at Google Scholar · View at Scopus
  78. O. I. Fregoso, S. Das, M. Akerman, and A. R. Krainer, “Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence,” Molecular Cell, vol. 50, no. 1, pp. 56–66, 2013. View at Publisher · View at Google Scholar · View at Scopus
  79. O. Anczuków, A. Z. Rosenberg, M. Akerman et al., “The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation,” Nature Structural and Molecular Biology, vol. 19, no. 2, pp. 220–228, 2012. View at Publisher · View at Google Scholar · View at Scopus
  80. P. E. Czabotar, G. Lessene, A. Strasser, and J. M. Adams, “Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy,” Nature Reviews Molecular Cell Biology, vol. 15, no. 1, pp. 49–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  81. A. Shimoni-Sebag, I. Lebenthal-Loinger, L. Zender, and R. Karni, “RRM1 domain of the splicing oncoprotein SRSF1 is required for MEK1-MAPK-ERK activation and cellular transformation,” Carcinogenesis, vol. 34, no. 11, pp. 2498–2504, 2013. View at Publisher · View at Google Scholar · View at Scopus
  82. H. L. Gautrey and A. J. Tyson-Capper, “Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells,” PLoS ONE, vol. 7, no. 12, Article ID e51497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Leu, Y.-M. Lin, C.-H. Wu, and P. Ouyang, “Loss of Pnn expression results in mouse early embryonic lethality and cellular apoptosis through SRSF1-mediated alternative expression of Bcl-xS and ICAD,” Journal of Cell Science, vol. 125, no. 13, pp. 3164–3172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. X. Li, J. Wang, and J. L. Manley, “Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation,” Genes and Development, vol. 19, no. 22, pp. 2705–2714, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. N. A. Olshavsky, C. E. S. Comstock, M. J. Schiewer et al., “Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene,” Cancer Research, vol. 70, no. 10, pp. 3975–3984, 2010. View at Publisher · View at Google Scholar · View at Scopus
  86. F. Wang, H. Wang, H. Wu et al., “TEAD1 controls C2C12 cell proliferation and differentiation and regulates three novel target genes,” Cellular Signalling, vol. 25, no. 3, pp. 674–681, 2013. View at Publisher · View at Google Scholar · View at Scopus
  87. R. Karni, Y. Hippo, S. W. Lowe, and A. R. Krainer, “The splicing-factor oncoprotein SF2/ASF activates mTORC1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 40, pp. 15323–15327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. V. Ben-Hur, P. Denichenko, Z. Siegfried et al., “S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1,” Cell Reports, vol. 3, no. 1, pp. 103–115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. T. Ezponda, M. J. Pajares, J. Agorreta et al., “The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression,” Clinical Cancer Research, vol. 16, no. 16, pp. 4113–4125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. Fu, B. Huang, Z. Shi et al., “SRSF1 and SRSF9 RNA binding proteins promote Wnt signalling-mediated tumorigenesis by enhancing β-catenin biosynthesis,” EMBO Molecular Medicine, vol. 5, no. 5, pp. 737–750, 2013. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Ghigna, S. Giordano, H. Shen et al., “Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene,” Molecular Cell, vol. 20, no. 6, pp. 881–890, 2005. View at Publisher · View at Google Scholar · View at Scopus
  92. P. Jordan, R. Brazão, M. G. Boavida, C. Gespach, and E. Chastre, “Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors,” Oncogene, vol. 18, no. 48, pp. 6835–6839, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Schnelzer, D. Prechtel, U. Knaus et al., “Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b,” Oncogene, vol. 19, no. 26, pp. 3013–3020, 2000. View at Publisher · View at Google Scholar · View at Scopus
  94. P. Matos, J. G. Collard, and P. Jordan, “Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling,” The Journal of Biological Chemistry, vol. 278, pp. 50442–50448, 2003. View at Publisher · View at Google Scholar
  95. D. Fiegen, L.-C. Haeusler, L. Blumenstein et al., “Alternative splicing of rac1 generates Rac1b, a self-activating GTPase,” Journal of Biological Chemistry, vol. 279, no. 6, pp. 4743–4749, 2004. View at Publisher · View at Google Scholar · View at Scopus
  96. V. Gonçalves, P. Matos, and P. Jordan, “Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways,” Human Molecular Genetics, vol. 18, no. 19, pp. 3696–3707, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. P. Matos and P. Jordan, “Expression of Rac1b stimulates NF-κB-mediated cell survival and G1/S progression,” Experimental Cell Research, vol. 305, no. 2, pp. 292–299, 2005. View at Publisher · View at Google Scholar · View at Scopus
  98. P. Matos and P. Jordan, “Increased Rac1b expression sustains colorectal tumor cell survival,” Molecular Cancer Research, vol. 6, no. 7, pp. 1178–1184, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. A. Maimon, M. Mogilevsky, A. Shilo et al., “Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras -induced transformation,” Cell Reports, vol. 7, no. 2, pp. 501–513, 2014. View at Publisher · View at Google Scholar · View at Scopus
  100. F. J. de Miguel, R. D. Sharma, M. J. Pajares, L. M. Montuenga, A. Rubio, and R. Pio, “Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer,” Cancer Research, vol. 74, no. 4, pp. 1105–1115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  101. D. G. Nowak, J. Woolard, E. M. Amin et al., “Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors,” Journal of Cell Science, vol. 121, no. 20, pp. 3487–3495, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. E. S. Rennel, A. H. R. Varey, A. J. Churchill et al., “VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo,” British Journal of Cancer, vol. 101, no. 7, pp. 1183–1193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  103. S. Oltean, M. Gammons, R. Hulse et al., “SRPK1 inhibition in vivo: modulation of VEGF splicing and potential treatment for multiple diseases,” Biochemical Society Transactions, vol. 40, no. 4, pp. 831–835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. M. N. Thobe, D. Gurusamy, P. Pathrose, and S. E. Waltz, “The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells,” Oncogene, vol. 29, no. 2, pp. 214–226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  105. A. F. Muro, M. Caputi, R. Pariyarath, F. Pagani, E. Buratti, and F. E. Baralle, “Regulation of fibronectin EDA exon alternative splicing: possible role of RNA secondary structure for enhancer display,” Molecular and Cellular Biology, vol. 19, no. 4, pp. 2657–2671, 1999. View at Google Scholar · View at Scopus
  106. I. C. Lopez-Mejia, M. de Toledo, F. Della Seta et al., “Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion,” Molecular Biology of the Cell, vol. 24, no. 20, pp. 3164–3176, 2013. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Adesso, S. Calabretta, F. Barbagallo et al., “Gemcitabine triggers a pro-survival response in pancreatic cancer cells through activation of the MNK2/eIF4E pathway,” Oncogene, vol. 32, no. 23, pp. 2848–2857, 2013. View at Publisher · View at Google Scholar · View at Scopus
  108. J. C. Shultz, R. W. Goehe, C. S. Murudkar et al., “SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells,” Molecular Cancer Research, vol. 9, no. 7, pp. 889–900, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. J. C. Shultz, R. W. Goehe, D. S. Wijesinghe et al., “Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a,” Cancer Research, vol. 70, no. 22, pp. 9185–9196, 2010. View at Publisher · View at Google Scholar · View at Scopus